Engineering Antibody-Based Molecules that Reshape Immune Cell Behavior for Targeted Treatment of Cancer
Time: 4:00 pm
day: Conference Day One
Details:
- Cytokine/anti-cytokine antibody fusion proteins (immunocytokines) selectively deliver cytokines to particular immune cell subsets through distinct structural and molecular effects
- Immunocytokines promote effector-T and natural killer cell expansion to mount potent antitumor effects
- Tumor-targeted delivery of immunocytokines improves safety and efficacy of cancer treatment regimens
